Standard Form Name: Vismodegib
Other Names:
25X868M3DS
2-chloro-n-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)benzamide
2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide
2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide
2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide
2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide
879085-55-9
AK-77261
AOB1040
C19H14Cl2N2O3S
CHEBI:66903
CHEMBL473417
CTK8B8648
CUR-691
D03EDQ
D0LB7J
Erivedge
Erivedge (TN)
GDC 0449
GDC-0449
GDC0449
GDC-0449 - Selumetinib
GDC-0449(Vismodegib)
GDC-0449,Vismodegib
GDC-0449 (Vismodegib)
GTPL6975
Hh-Antag691
HhAntag 691
HhAntag691
HSDB 8130
methanesulfonylbenzamide
MLS006012035
NSC 747691
NSC-747691
NSC747691
NSC755986
PubChem19137
QCR-40
R 3616
R-3616
RG-3616
SCHEMBL302587
UNII-25X868M3DS
Vismodegib
Vismodegib, free base
Vismodegib (GDC-0449)
Vismodegib (SHH inhibitor)
vismodegibum
Vismodegib (USAN/INN)
Vismodegib [USAN:INN]
IUPAC name:
2-chloro-~{N}-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide
PUBCHEM:
24776445
InChIKey:
BPQMGSKTAYIVFO-UHFFFAOYSA-N
InChI:
1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)
Image of the Standard Form:
Corresponding Specific State(s)
| Specific State ID: 5116 |
| |
